Information Provided By:
Fly News Breaks for November 5, 2018
IDXX
Nov 5, 2018 | 07:35 EDT
Canaccord analyst Mark Massaro lowered his price target on Idexx Laboratories to $250 from $270 following its Q3 results. The analyst said the company remains the best-in-class large cap growth leader in the global animal market and reset its guidance bar as readily achievable. Massaro maintained his Buy rating on Idexx Laboratories shares.
News For IDXX From the Last 2 Days
There are no results for your query IDXX